Veradigm | MDRX - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
Alcidion AUD 89.64M 1.84M 2025-12
Ambu A/S DKK 6.1B 65M 2026-03
Amplifon EUR 1.08B 78.22M 2026-03
Cardinal Health USD -2.83B 52M 2026-03
Centene USD 22.56B 1.14B 2026-06
Charles River Laboratories USD 2.9B 265.94M 2026-03
Cigna USD 42.21B 497M 2026-03
Coloplast 13.8B 2.32B 2025-12
Convatec Group USD 1.69B 34M 2024-12
CVS Health USD 77.46B 2.24B 2026-03
Diasorin EUR 1.53B 151.64M 2025-06
Elevance Health USD 44.88B 981M 2026-06
General Electric Aerospace USD 17.64B 417M 2026-06
Gulf Medical Proj AED 1.22B 56.38M 2025-12
Humana USD 18.58B 923M 2026-03
IQVIA Holdings USD 6.17B 50M 2026-06
Laboratory Of America USD 8.73B 108.8M 2026-03
Maximus USD 1.7B 22.85M 2026-03
McKesson USD -2.17B 874M 2026-03
Med Life RON 483.77M 18.26M 2025-12
Molina Healthcare USD 4.17B 91M 2026-06
Omnicell USD 1.26B 24.82M 2026-03
Oriola-kd EUR 92.8M 8M 2026-03
Owens Minor USD -464.76M 3.79M 2026-03
Quest Diagnostics USD 7.52B 150M 2026-06
Rede D'or Sao Luiz BRL 22.34B 2.98B 2026-03
Siemens Healthineers EUR 18.21B 217M 2026-03
Sonova Holding CHF 2.66B 374.5M 2025-06
Supermax Corporation Bhd MYR 3.77B 44.17M 2026-03
UnitedHealth USD 105.32B 3.62B 2026-03
Veeva Systems USD 7.3B 89.6M 2026-03
Veradigm USD 1.02B 159.52M 2022-12
Xerox USD 299M 145M 2026-03